By Abigirl Tembo
THE Government is clinically testing the anti-parasite drug, Ivermectin (ayivemectin) to establish its effectiveness in fighting the COVID-19 pandemic.
In a communique written to the Medicines Control Authority of Zimbabwe, the Acting Permanent Secretary in the Ministry of Health and Child Care Dr Robert Mudyiradima authorised the importation and use of Ivermectin under strict guidelines.
The move has been welcomed by the Medical and Dental Private Practitioners of Zimbabwe.
“More than 3 billion doses of this drug has been dispersed so far and there has been so many research done on the efficacy of this drug so it’s high time we also start conducting clinical trials.”
Chief coordinator national response to the Covid-19 pandemic, Dr Agnes Mahomva is urging people to use it under a strict monitored approach.
“It has been on the W.H.O list for treating parasites. There is the one for animals and humans. The data that has been shown so far is showing some positive results but it is still under clinical trials; for now people can use it under that guided structured monitored approach because this is an emergency.”
Medicines Control Authority of Zimbabwe Projects and Public Relations Officer Shingai Gwatidzo says it is an opportunity for stakeholders in the health sector to gather data as the nation battles to control the spread of Covid-19.
“This approval is not a blanket approach rather this is an opportunity for stakeholders to gather data and see whether it has therapeutic value in the management of Covid-19.”
Human Ivermectin has been approved in many countries, including the UK and India, while its possible use is being explored in the United States and Australia.